Muhammad Hameed Khan | Epidemiology | Editorial Board Member

Published on by Global Academic Awards

Mr. Muhammad Hameed Khan | Epidimiology | Editorial Board Member

Quaid-i-Azam University | Pakistan

Mr. Muhammad Hameed Khan is an emerging researcher in medical entomology, parasitology, and infectious disease ecology, with strong expertise in molecular diagnostics, epidemiology, and vector-borne disease surveillance. His research integrates molecular tools, biodiversity assessment, and ecological mapping to investigate malaria dynamics, hard-tick infestations, measles epidemiology, tuberculosis prevalence, and the bioactivity of plant-based nanoparticles. He has contributed to impactful studies on queen bee rearing, silver nanoparticle synthesis, and emerging public health threats, demonstrating versatility across entomology, biotechnology, and disease prevention. His technical strengths span PCR, DNA extraction, ArcGIS mapping, nanoparticle preparation, microscopy, and bioinformatics, supported by excellent analytical, leadership, and independent research capabilities. With multiple publications, conference participations, and organizational roles in scientific events, he is committed to advancing vector control strategies, molecular parasitology, and integrated pest management, making him a strong candidate for competitive research awards and future academic excellence.

Profile: Google Scholar

Featured Publications

1. Khan, M. S., Butt, N., Khan, M. H., Shoaib, M., & Javed, M. (2021). Impact of COVID-19 on the hospitality industry: A review of current findings. Journal of Hospitality and Tourism Management, 46, 205–215.

2. Rehman, N. U., Anjum, S. I., Qureshi, N. A., Khan, M. H., Albasher, G., Kaleem, M., … (2024). The effect of larval age, and wet and dry grafting, on the rearing of queen bees using the Doolittle grafting method. Entomological Research, 54(1), e12700.

3. Siraj, N. (2025). Morphomolecular identification and spatiotemporal distribution of hard ticks infesting cattle: A livestock and public health concern in selected localities of District Swat. The Research of Medical Science Review, 3(5), 33–52.
(If M. H. Khan is a co-author, it may be added accordingly.)

4. Muhammad, M. J. U., Khan, M. H., Siraj, N., Saeed, M. A., Shah, M., … (2024). Green synthesis, characterization, optimization and anti-leishmanial investigation of silver nanoparticles from Citrus sinensis L. fruit peels. Journal of Population Therapeutics & Clinical Pharmacology, 31(10), 382–392.

5. Khan, M. S. M. H., Siraj, N., Khan, A. G., & Ali, S. (2024). Epidemiological patterns, risk factors, and preventive strategies associated with measles infection in children of Tehsil Matta, District Swat, Pakistan. Journal of Population Therapeutics & Clinical Pharmacology, 31.

Victor Wallis | Public Health | Best Researcher Award

Published on by Global Academic Awards

Prof. Victor Wallis | Public Health | Best Researcher Award

Berklee College of Music | United States

Prof. Victor Wallis, from Berklee College of Music, Boston, United States, is a distinguished researcher specializing in social theory, political economy, and public health. His work critically examines capitalism, socialism, and policy formation, addressing contemporary societal challenges, including the impact of COVID-19 on governance and social structures. With 72 scholarly publications, including open-access articles such as Covid-19 in the History of Capitalism and The Impact of Censorship on COVID-19 Policy Formation in the United States, alongside book chapters in respected outlets like Monthly Review and Socialism and Democracy, Prof. Victor Wallis demonstrates a strong and diverse research portfolio. His scholarship has been cited 203 times across 163 documents, with an h-index of 8, reflecting significant influence and academic recognition. Collaborating with 14 co-authors, his contributions bridge rigorous academic inquiry and social critique, highlighting his relevance and impact in contemporary research, making him a strong candidate for the Best Researcher Award.

Profile: Scopus

Featured Publications

  • Wallis, V. (2025). Covid-19 in the history of capitalism. Capitalism Nature Socialism.

  • Wallis, V. (n.d.). Limits to growth

  • Wallis, V. (n.d.). Katsiaficas, George

  • Wallis, V. (n.d.). Monthly Review

  • Wallis, V. (n.d.). Zeitlin, Maurice

  • Wallis, V. (n.d.). Socialism and Democracy

  • Wallis, V. (n.d.). The Impact of Censorship on COVID-19 Policy Formation in the United States

 

Dejan Milentijevic | Pharmacoeconomics | United States

Published on by Global Academic Awards

Dr. Dejan Milentijevic | Pharmacoeconomics | United States

Janssen Pharmaceuticals | United States

Dr. Dejan Milentijevic is a dynamic and accomplished Health Economics and Outcomes Research (HEOR) Executive with extensive experience in delivering actionable insights and driving strategic decision-making across the pharmaceutical, biotech, and medical device sectors. Renowned for his expertise in oncology, immunology, cardiovascular, and gene therapies, he excels at navigating complex therapeutic landscapes to enhance market access and inform healthcare policy. He skillfully integrates economic modeling, observational studies, real-world evidence, and patient-centered outcomes to optimize payer engagement, guide product launches, and improve patient outcomes. At Johnson & Johnson, he has led transformative initiatives in neuroscience, gene therapy, and cardiovascular portfolios, leveraging cross-functional collaboration, innovative data analytics, and AI-driven approaches to generate evidence supporting lifecycle management and value-based agreements. His prior roles at Celgene Corporation and Market Access Solutions further demonstrate his leadership in real-world evidence generation, budget impact modeling, and strategic market access planning. Dr. Dejan Milentijevic holds a Ph.D. in Biomedical Sciences from Weill Cornell Medical College, an MBA from Rutgers Business School, and advanced technical proficiency in SAS, SPSS, Python, and R statistical programming. With 750 citations, 31 published documents, and an h-index of 12, his research has significantly influenced payer decisions, scientific publications, and healthcare outcomes, underscoring his exceptional impact and ongoing contributions to evidence-based healthcare.

Profile: Scopus | Orcid

Featured Publications

Milentijevic, D., Lin, J. H., Chen, Y.-W., Kogan, E., Shrivastava, S., Sjoeland, E., & Alberts, M. (2021). Healthcare costs before and after stroke in patients with non-valvular atrial fibrillation who initiated treatment with rivaroxaban or warfarin. Journal of Medical Economics.

Khorana, A. A., McCrae, K., Milentijevic, D., McCormick, N., Laliberté, F., Crivera, C., Lefebvre, P., Lejeune, D., Rozjabek, H., Schein, J., et al. (2019). The risk of recurrent VTE and major bleeding in a commercially‐insured population of cancer patients treated with anticoagulation. American Journal of Hematology.

Streiff, M. B., Milentijevic, D., McCrae, K., Yannicelli, D., Lejeune, D., Nelson, W. W., Laliberté, F., Crivera, C., Lefebvre, P., Schein, J., et al. (2018). An answer to “anticoagulant treatment of cancer‐associated venous thromboembolism: Interpreting real‐world data with caution.” American Journal of Hematology.

Streiff, M. B., Milentijevic, D., McCrae, K., Yannicelli, D., Fortier, J., Nelson, W. W., Laliberté, F., Crivera, C., Lefebvre, P., Schein, J., et al. (2018). Effectiveness and safety of anticoagulants for the treatment of venous thromboembolism in patients with cancer. American Journal of Hematology.

Sémah Tagougui | Exercise | Best Researcher Award

Published on by Global Academic Awards

Dr. Sémah Tagougui | Exercise | Best Researcher Award

Dr. Sémah Tagougui at University of Lille, France

Dr. Sémah Tagougui is a University Lecturer at the University of Lille  and an internationally recognized researcher in exercise physiology, type 1 diabetes, and metabolic health 🧠. With a Ph.D. in Life Sciences and postdoctoral training in Brussels and Montreal , he leads innovative projects on glycemic control, including AI-based tools  and insulin technologies. He has secured competitive grants , published high-impact research 📚, and regularly speaks at global conferences. Honored with the RIPEC Award for Scientific Excellence 🏅, Dr. Tagougui’s work bridges clinical science and real-world application for chronic disease management 🩺.

Publication Profile

Orcid

Scopus

Google Scholar

Academic Background

Dr. Sémah Tagougui holds a Ph.D. in Life Sciences from the University of Lille , where his research focused on muscle and cerebral oxygenation in individuals with type 1 diabetes 💉. He also earned a Master’s degree in Adapted Physical Activities and Health from the same university 🏃‍♂️🩺. He completed two prestigious postdoctoral fellowships—one in Brussels  and another at the Institute of Clinical Research in Montreal . In 2022, he received his Habilitation to Supervise Research, a mark of academic excellence 🏅. His educational path reflects a strong commitment to clinical and physiological research 📚.

Professional Experience

Dr. Sémah Tagougui is currently serving as a University Lecturer at the University of Lille , where he has been actively teaching and conducting research since 2019 📚. He previously held roles as an ATER and doctoral tutor at the same university, shaping future professionals in sports science and health 🧠. His international experience includes postdoctoral research positions in Brussels  and Montreal , focusing on diabetes, exercise physiology, and metabolic health 💉. Dr. Tagougui also plays key roles in international collaborative projects , thesis committees , and scientific advisory panels, demonstrating leadership in academic and clinical research 🔬🩺.

Awards and Honors

Dr. Sémah Tagougui has received several prestigious awards in recognition of his outstanding contributions to science and health research 💉. In 2023, he was honored with the RIPEC Award for Scientific Excellence by the French National Council of Universities 🎖️. He also secured multiple competitive grants, including the Young Francophone Researcher Grant and the FRM Research Hope Grant 📑. His invited speaker roles at renowned institutions and conferences 🌍 further highlight his influence in the field. These accolades reflect his dedication to advancing knowledge in type 1 diabetes, exercise science, and metabolic health 🔬.

Research Focus

Dr. Sémah Tagougui’s research centers on the intersection of type 1 diabetes, exercise physiology, and metabolic health 💉. His work explores how physical activity impacts glycemic control, muscle oxygenation, and cerebral function in individuals with diabetes . He is actively developing AI-powered tools for personalized blood glucose prediction  and has contributed to cutting-edge studies on insulin technologies, artificial pancreas systems, and exercise-induced glucose fluctuations 🧬. Collaborating internationally , his goal is to transform exercise from a risk factor into a therapeutic strategy for diabetes management 🌍. His research has real-world clinical impact and global relevance 🌐📚.

Publication Top Notes

Acute cocoa flavanol improves cerebral oxygenation without enhancing executive function at rest or after exercise
📅 Year: 2016 | 🔢 Cited by: 68

The benefits and limits of technological advances in glucose management around physical activity in patients with type 1 diabetes
📅 Year: 2019 | 🔢 Cited by: 62

Muscle oxygen supply impairment during exercise in poorly controlled type 1 diabetes
📅 Year: 2015 | 🔢 Cited by: 62

Artificial pancreas systems and physical activity in patients with type 1 diabetes: challenges, adopted approaches, and future perspectives
📅 Year: 2019 | 🔢 Cited by: 52

Aerobic fitness influences cerebral oxygenation response to maximal exercise in healthy subjects
📅 Year: 2015 | 🔢 Cited by: 38

A single-blind, randomised, crossover study to reduce hypoglycaemia risk during postprandial exercise with closed-loop insulin delivery in adults with type 1 diabetes
📅 Year: 2020 | 🔢 Cited by: 35

Muscle oxygen supply and use in type 1 diabetes: is there a limiting step?
📅 Year: 2020 | 🔢 Cited by: 33

Barriers to physical activity in children and adults living with type 1 diabetes: a complex link with real-life glycemic excursions
📅 Year: 2023 | 🔢 Cited by: 31

Changes in accuracy of continuous glucose monitoring using Dexcom G4 Platinum during moderate intensity exercise in type 1 diabetes
📅 Year: 2019 | 🔢 Cited by: 27

Regional cerebral hemodynamic response to incremental exercise is blunted in poorly controlled patients with uncomplicated type 1 diabetes
📅 Year: 2015 | 🔢 Cited by: 22

Minimizing risk of exercise-induced glucose fluctuations in type 1 diabetes using insulin infusion: overview of strategies
📅 Year: 2021 | 🔢 Cited by: 19

Effectiveness of Ramadan fasting and concurrent training in obesity management: is the combination worth the weight?
📅 Year: 2023 | 🔢 Cited by: 18

Conclusion

Dr. Sémah Tagougui is an outstanding candidate for the Best Researcher Award due to his exemplary academic background, including a distinguished Ph.D. and postdoctoral fellowships, along with his habilitation to supervise research, demonstrating senior scientific leadership. As a University Lecturer at the University of Lille, he has led numerous competitive international grants and acted as Principal Investigator on innovative projects bridging exercise physiology and diabetes management. His high-impact publications in top journals and extensive citations reflect significant contributions to the field. Dr. Tagougui’s strong international collaborations, invited speaker roles, and translational focus on improving clinical outcomes highlight his sustained excellence, making him highly deserving of this honor.

 

 

Barsha Gadapani Pathak | Public Health | Women Researcher Award

Published on by Global Academic Awards

Dr. Barsha Gadapani Pathak | Public Health | Women Researcher Award

Dr. Barsha Gadapani Pathak, University of Bergen and Society for Applied Studies, India

Dr. Barsha Gadapani Pathak is an Indian physician-scientist specializing in public health and implementation science, with a focus on maternal and child health. She is currently pursuing her Ph.D. at the University of Bergen, Norway, and serves as a Scientist at the Society for Applied Studies, New Delhi. With extensive experience in research, policy engagement, and program implementation, she has led and contributed to multiple WHO- and ICMR-funded projects. Her work spans childhood pneumonia, stillbirth prevention, anemia reduction, and kangaroo mother care. She is also a Lancet Citizens’ Commission Fellow and an invited expert for national and international public health forums. 🌍📊👩‍⚕️

Publication Profile

Google Scholar

🎓 Education

Dr. Pathak is currently pursuing a Ph.D. in Public Health with a specialization in Implementation Science and Maternal-Child Health at the University of Bergen, Norway. She holds a Diploma in Community Mental Health from Rajendra Institute of Medical Sciences, Ranchi (2021), and an MD in Community Medicine from Seth GS Medical College & KEM Hospital, Mumbai (2019), where she ranked 3rd in the university. She earned her MBBS from BVP, Pune University in 2013. Her educational background integrates clinical knowledge with public health expertise, providing a strong foundation for her implementation research in health system strengthening. 🎓📚🩺

💼 Experience

Dr. Pathak currently serves as a Scientist at the Society for Applied Studies, New Delhi, since September 2024. Previously, she was a Research Scientist and Young Investigator with PRERNA from 2020 to 2024. She also worked as an Assistant Professor in Community Medicine at KEM Hospital, Mumbai, and as a Medical Officer with the National Health Mission, Assam. With over a decade of cross-disciplinary experience in academia, clinical settings, and global health research, she has contributed extensively to national health programs and WHO guideline development efforts, bridging field implementation with evidence-based policy making. 🧪🏥🌐

🏅 Awards and Honors

Dr. Pathak has received numerous accolades, including the Best Resident Award from the Municipal Corporation of Greater Mumbai (2019) and the Parimala Subramaniyan Award for excellence in Community Medicine (2018). She ranked 3rd in MD Community Medicine at the Maharashtra University of Health Sciences and earned a Certificate of Appreciation at an International Public Health Conference (2020). She has secured multiple prestigious grants from WHO, ICMR, and DJST, and has served as a speaker, expert panelist, and resource person in national and global forums, highlighting her dedication and leadership in advancing public health. 🏆🎖️📜

🔬 Research Focus

Dr. Pathak’s research focuses on implementation science in maternal and child health, particularly improving healthcare delivery for childhood pneumonia, stillbirth prevention, neonatal care (iKMC), and anemia control. She leads and collaborates on WHO- and ICMR-funded projects aimed at translating evidence into scalable health system interventions. Her work combines mixed-methods research with health systems strengthening to reduce mortality and improve care coverage. Additionally, she has contributed to national guidelines and global evidence syntheses on childhood pneumonia and low-birth-weight care. Her studies are impactful, policy-relevant, and grounded in community-based participatory approaches. 👶📈📑

Publication Top Notes

  • Effects of kangaroo mother care on maternal and paternal health: systematic review and meta-analysis – BG Pathak, B Sinha, N Sharma, S Mazumder, N Bhandari 🍼👶 – Cited by 40 – 2023

  • Obesity prevalence and determinants among young adults, with special focus on normal-weight obesity; a cross-sectional study in Mumbai – RS Hadaye, RM Manapurath, BP Gadapani 🍔⚖️ – Cited by 33 – 2020

  • Body composition of infants born with intrauterine growth restriction: a systematic review and meta-analysis – R Manapurath, B Gadapani, L Pereira-da-Silva 🍼📉 – Cited by 27 – 2022

  • Nutritional status of the student nurses of a tertiary health-care center–a mixed-method study – R Hadaye, B Pathak, S Lavangare 🥗💉 – Cited by 18 – 2019

  • Enteral low-dose vitamin A supplementation in preterm or low birth weight infants to prevent morbidity and mortality: a systematic review and meta-analysis – RM Manapurath, M Kumar, BG Pathak, R Chowdhury, B Sinha, … 💊🍼 – Cited by 14 – 2022

  • Mixed-method analysis of community health camps: A novel approach beckoning – A Bhondve, B Pathak, RM Manapurath 🏥👥 – Cited by 14 – 2019

  • Normal weight obesity: role of apoB and insulin sensitivity in predicting future cardiovascular risk – RM Manapurath, R Hadaye, B Gadapani 💔💉 – Cited by 8 – 2022

  • Awareness and acceptance of H1N1 vaccination among physicians: Experience of 2017 vaccination campaign – RS Hadaye, RM Manapurath, BP Gadapani 💉🦠 – Cited by 6 – 2019

  • Combating the pandemic of COVID-19 in India: Health care worker perspective – RMM Barsha Gadapani 🦠🏥 – Cited by 5 – 2020

  • Noncompliance of the postexposure prophylactic vaccination following animal bites reporting to a rural primary health center – RMM Barsha Gadapani, Rahini S 🐕💉 – Cited by 5 – 2019

  • Diet and lifestyle risk factors associated with young adult hypertensives in India–Analysis of National Family Health Survey IV – RM Manapurath, RM Anto, B Pathak, S Malhotra, P Khanna, S Goel 🥦🍔 – Cited by 4 – 2022

  • Analyzing the challenges and demotivating factors faced by accredited social health activist workers in tribal India in implementing their roles – RMM Swati Deshpande, Barsha Gadapani P 🏞️💪 – Cited by 4 – 2019

  • Tobacco smoking and blood pressure: How are they related among the Indians?–A secondary analysis of National Family Health Survey (NFHS)-4 data – BG Pathak, S Rahini, RM Manapurath, BN Sharath, R Gupta, S Goel 🚬💉 – Cited by 3 – 2022

  • Utilizing “Positive deviance inquiry” to explore factors influencing child health: A qualitative study – R Sabale, BG Pathak, RM Manapurath 🧒🩺 – Cited by 3 – 2021

  • Catalyzing healthcare accessibility through cashless payment gateways in India: a digital revolution – BG Pathak, G Mathew, V Chandru, MS Kamath 💳🏥 – Cited by 2 – 2024

Jane Warland | Health Professions | Best Researcher Award

Published on by Global Academic Awards

Assoc. Prof. Dr. Jane Warland | Health Professions | Best Researcher Award

Assoc. Prof. Dr. Jane Warland, University of Adelaide, Australia

Assoc. Prof. Dr. Jane Elizabeth Warland is a distinguished midwifery academic at the University of Adelaide Medical School, with a clinical title and extensive experience in both academic and clinical settings. With over three decades in maternal health, she has served in various hospitals and held prestigious academic positions across UniSA and Curtin University. Her work bridges clinical care and cutting-edge research, particularly in perinatal health and stillbirth prevention. Dr. Warland is widely respected for her leadership, teaching excellence, and impactful publications. She remains an influential voice in maternal and neonatal care. 🌿📚

Publication Profile

Orcid

Google scholar

🎓 Education

Dr. Warland holds a PhD in Medicine (Health Sciences) from the University of Adelaide (2007), which cemented her focus on maternal and fetal health research. She also earned a Graduate Certificate in Education (University Teaching) from UniSA in 2009, highlighting her commitment to academic excellence. Additionally, she became a Registered Midwife in 1989 at the Queen Victoria Hospital, South Australia (now WCH). These educational milestones laid a strong foundation for her blended career in research, teaching, and clinical practice. Her qualifications reflect a lifelong dedication to improving outcomes in maternity care and advancing midwifery education. 🎓📖

💼 Experience

Dr. Warland’s professional journey includes decades as a Registered Nurse and Midwife from 1988 to 2007, serving in prominent South Australian hospitals. Transitioning into academia in 2008, she has held roles from Lecturer to Associate Professor, teaching research, midwifery practice, and perinatal health. Notably, she was Joint Chair at Curtin University/King Edward Memorial Hospital (2021–2023). At UniSA, she coordinated multiple courses and mentored students in midwifery and health sciences. Her dual experience in hands-on clinical care and academic leadership has significantly shaped maternal health education and policy across Australia. 🏥📘

🏆 Awards & Honors

While specific award titles are not explicitly listed, Dr. Warland’s long-standing leadership positions, joint academic chair roles, and continued appointments at major Australian universities highlight her recognition as a leading expert in her field. Her impact in stillbirth research and health communication strategies for pregnant women has earned her respect in national and international maternal health circles. Through honors such as research supervision, course coordination, and invitations to collaborative roles, she has consistently demonstrated academic excellence and professional dedication in midwifery science. 🏅🌟

🔬 Research Focus

Dr. Warland’s research primarily centers on stillbirth prevention, perinatal mental health, pregnancy health messaging, maternal sleep positions, and fetal well-being. Her interdisciplinary approach explores how behavioral and environmental factors influence pregnancy outcomes. She has supervised research on health communication, anxiety reduction in pregnant women, and fetal health awareness. With expertise spanning both psychology and midwifery, she bridges research with real-world applications to improve prenatal care. Her scholarship contributes to national awareness campaigns and informs guidelines for safer pregnancies. 🧠👶📊

Publication Top Notes

📚 Maternal sleep during pregnancy and poor fetal outcomes: a scoping review – 228 citations, 2018 🔍🍼
📚 Help-seeking for mental health problems in young refugees – 208 citations, 2009 🧠🌍
📚 Bearing witness: midwives experiences of witnessing traumatic birth – 177 citations, 2013 🍼😔
📚 Leadership in learning and teaching in higher education – 137 citations, 2015 🎓👩‍🏫
📚 Seeing and holding a stillborn baby: Mothers’ feelings – 119 citations, 2013 💔🍼
📚 Evidence for nursing practice – 118 citations, 2005 📘🩺
📚 STARS cohort study on late stillbirth experiences – 107 citations, 2015 👩‍🍼🌐
📚 Parenting paradox: parenting after infant loss – 103 citations, 2011 👨‍👩‍👧‍👦💔
📚 Umbilical cord characteristics and adverse outcomes – 85 citations, 2020 🔬🧬
📚 A triple risk model for unexplained late stillbirth – 84 citations, 2014 ⚠️🍼
📚 Understanding stillbirth stigma – 79 citations, 2020 🗣️🧠
📚 Assertiveness training for midwifery students – 77 citations, 2014 🧑‍⚕️🗯️
📚 Untold stories of infant loss – 76 citations, 2013 🍼💬

 

Tiantian Zhang | Health Professions | Best Researcher Award

Published on by Global Academic Awards

Dr. Tiantian Zhang | Health Professions | Best Researcher Award

Dr. Tiantian Zhang, Fudan University, China

Dr. Tiantian Zhang is a dedicated researcher in the field of public health, specializing in the construction of public health systems and proactive health technologies within the context of medical health big data. Currently serving as a Youth Researcher at the School of Public Health at Fudan University since October 2023, she brings an academic background with a Master’s and Doctorate in Management, focusing on social medicine and health management from Fudan University. She has contributed significantly to over 38 publications, with many in high-impact journals, particularly in health policy, public health emergency responses, and chronic disease prevention. Her research also covers the intersection of technology, public health, and healthcare systems. She has been involved in various research projects and has received substantial funding for her work. Dr. Zhang’s academic journey includes postdoctoral research and entrepreneurial experience in management science and data science. Additionally, she is a key member of national projects on public health and disease prevention.

 

Publication Profile

Scopus

Academic Background 🎓📚

Dr. Tiantian Zhang pursued her graduate studies at Fudan University, where she earned a Master’s degree in Management with a focus on Social Medicine and Health Administration from September 2016 to June 2018. 🏫🎓 She continued her academic journey at Fudan, completing a PhD in Management in the same field from June 2018 to June 2021. 🔬 Her doctoral research contributed to advancing public health management and policy, further establishing her expertise in healthcare systems and social medicine. Dr. Zhang’s academic foundation laid the groundwork for her current work in public health and health data research. 🌟📊

 

Professional and Visiting Scholar Experience 💼🌍

Dr. Tiantian Zhang has held various esteemed positions in her career. Since October 2023, she has been serving as a Youth Researcher at Fudan University, focusing on Health Management. 🏫🧑‍🔬 From June 2021 to September 2023, she worked as a Postdoctoral Researcher at Fudan University, specializing in Public Policy. 📜🔍 Additionally, since September 2017, Dr. Zhang has been the founder and legal representative of Shanghai Haiyu Information Technology Co., Ltd., where she applies her expertise in Management Science and Data Science. 💻📊 Her diverse roles reflect her commitment to advancing healthcare and policy through innovation. 🌟

 

Research Achievements and Contributions 📚🏆

Dr. Tiantian Zhang, a Youth Researcher at Fudan University’s School of Public Health, has made significant contributions to healthcare management research. She has co-authored 9 policy briefs, receiving positive feedback from top political leaders, including members of the Central Political Bureau. 👩‍🔬✨ She has led a National Natural Science Foundation Youth Project and 7 provincial projects, while also contributing to major national R&D initiatives. Her research includes 37 published papers, 8 of which are in high-impact journals (SCI/SSCI, JCR-Q1), with a total impact factor of 68.5. 📝📊 Dr. Zhang has received multiple prestigious awards, including the Shanghai Decision-Making Advisory Research Awards and the Shanghai Youth Medal. 🏅

 

Academic Positions and Editorial Roles 📚🌟

Dr. Tiantian Zhang holds several prestigious academic roles. She is a Youth Elite Talent for the Shanghai Municipal Government Decision-Making Consulting Research Base (2024–2026) and an expert in Shanghai’s healthcare reform (2022–2025). 🏅 She serves on the Youth Committee of the Shanghai Medical Association’s Health Management Branch and is a director of the Chinese Medicine Informatics Society. 🩺 Additionally, she contributes to several academic journals, including Chinese Hospital Management and Chinese Public Health Management, where she holds youth editorial board positions. ✍️ She is also involved in writing and editing key publications, including the fifth edition of Health Management and the Blue Book on Proactive Health and Healthy Aging. 📖

 

Research Focus

Dr. Tiantian Zhang’s research focuses on public health management, health policy, and health data science. She is particularly interested in the intersection of healthcare system development and technology for proactive health and aging. 🏥 Her work includes studies on health equity, air pollution, dyslipidemia, and disease prevention, and she frequently contributes to research on health disparities and socioeconomic factors affecting public health. 🌍 Additionally, she explores health management practices and decision-making frameworks for improving healthcare services, with a strong emphasis on government regulation and community-based health interventions. 📊

 

Publication Top Notes  

  • Association of circadian syndrome with risk of hyperuricemia among middle-aged and older adults in China – 2025 🕰️,
  • Research on government regulation methods for the spatial layout of retail pharmacies – 2024 🏪
  • Prevalence of dyslipidemia and associated factors in sedentary occupational population from Shanghai – 2024 ⚖️,
  • Global Justice Index Report 2023 – 2024 🌍, Cited by: 2 📑.
  • Association of long-term exposure to air pollutants with sensory impairment in middle-aged and elderly adults – 2024 🌫️
  • Equity analysis of older adult resource allocation in China – 2024 💼
  • Development of an assessment tool for designated medical institutions in China – 2024 💻
  • Association of indoor solid fuel use and long-term exposure to ambient PM2.5 with sarcopenia in China – 2023 🌫️, Cited by: 10 📑.
  • Global Justice Index Report 2022 – 2023 🌍, Cited by: 7 📑.

 

Haojie Shan | Medicine and Dentistry | Best Researcher Award

Published on by Global Academic Awards

Dr. Haojie Shan | Medicine and Dentistry | Best Researcher Award

Dr. Haojie Shan, Department of orthopedic surgery, Shanghai Sixth People’s Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, China

Dr. Haojie Shan is a dedicated Resident Surgeon at the Department of Orthopaedic Surgery, Shanghai Sixth People’s Hospital, affiliated with Shanghai Jiao Tong University. He holds a Ph.D. and M.D. in Orthopaedic Surgery from the same university and a B.S. in Clinical Medicine from Henan University. His research interests include osteonecrosis of the femoral head, bone immunity, and biomedical materials. Dr. Shan has authored numerous publications and holds several patents in surgical innovation. He has received prestigious awards, including a Gold Award in the International Innovation Competition for College Students in China. 📚🏆🦴

 

Publication Profile

Scopus

Education

Dr. Haojie Shan completed his academic journey in the field of orthopaedic surgery with impressive credentials. He earned his Ph.D. in Surgery (Orthopaedics) from Shanghai Jiao Tong University in June 2023, following the completion of his M.D. in the same specialty in June 2020. Prior to that, he obtained his B.S. in Clinical Medicine from Henan University in June 2017. Dr. Shan’s extensive education reflects his dedication to advancing medical knowledge and surgical techniques in orthopaedics. 🦴🎓🏥

 

Research Interests

Dr. Haojie Shan is deeply engaged in innovative research within the field of orthopaedics, focusing on several critical areas. His primary interests include osteonecrosis of the femoral head, where he explores its underlying mechanisms and treatment strategies. He also investigates bone immunity and regeneration, aiming to enhance healing processes. Furthermore, Dr. Shan studies bone and soft tissue infections, seeking to improve diagnosis and therapeutic approaches. His work extends to the development and application of biomedical materials, which play a crucial role in orthopaedic surgery. His research contributes significantly to advancing patient care and treatment outcomes. 🦴🔬💉✨

 

Honors and Awards

Dr. Haojie Shan has garnered numerous accolades for his exceptional contributions to the field of orthopaedics and medical innovation. In 2024, he received the Gold Award in the Shanghai Division and a National Silver Award at the International Innovation Competition for College Students in China. His achievements include winning the First Prize at the 12th International Conference on Rehabilitation Medicine and Engineering Innovation Competition in 2023. Additionally, he secured the Second Prize for “Outstanding Youth” Papers at the same conference. Dr. Shan also earned a Third Prize in the China Medical Device Innovation and Entrepreneurship Competition and received recognition at various other esteemed events. 🥇🏆🎖️✨

 

Conclusion

Dr. Haojie Shan’s combination of education, research expertise, innovative contributions, and recognition in the orthopaedic surgery domain make him a highly suitable candidate for the Research for Best Researcher Award. His work not only demonstrates academic excellence but also a profound commitment to advancing medical science for improved patient outcomes.

 

Publication Top Notes  

  • A chitosan/gelatin/aldehyde hyaluronic acid hydrogel coating releasing calcium ions and vancomycin in pH response to prevent the formation of bacterial biofilm – Li, Y., Sung Min, H., Chen, C., … Lu, L., Yu, X. (2025) – 0 citations 📜
  • Copper-infused zinc porphyrin supramolecular polymersomes for triple synergistic combat against wound bacterial biofilm infections – Yang, L., Du, Y., Yin, F., … Zhou, Y., Yu, X. (2024) – 0 citations 💉
  • An Intelligent Hydrogel Platform with Triple-Triggered On-Demand Release for Accelerating Diabetic Wound Healing – Zhang, X., Li, Y., Zhao, Z., … Ren, R., Du, C., Yu, X. (2024) – 0 citations 🩹
  • Scd-1 deficiency promotes the differentiation of CD8+ T effector – Lin, Y., Li, X., Shan, H., … Liu, F., Yu, X. (2024) – 1 citation 💉
  • Effects of astragaloside IV on glucocorticoid-induced avascular necrosis of the femoral head via regulating Akt-related pathways – Shan, H., Lin, Y., Yin, F., … Zhou, Z., Yu, X. (2023) – 4 citations ⚖️
  • Dimethyl Oxalylglycine Activates Tendon-Derived Stem Cells to Promote Regeneration of Achilles Tendon Rupture in Rats via HIF-1α – Wang, Y., Li, M., Lin, Y., … Shan, H., Wu, T., Yu, X. (2023) – 2 citations 🦵
  • The Ubiquitination of RIPK2 is Mediated by Peli3 and Negatively Regulates the Onset of Infectious Osteomyelitis – Le, L., Shan, H., Lin, Y., … Shi, Z., Xu, Y., Yu, X. (2023) – 0 citations 🦠
  • Ubiquitin-Specific Peptidase 8 Is Critical for the Onset of Infectious Osteomyelitis by Targeting RIPK2 Ubiquitination – Chen, Y., Wan, Y., Shan, H., … Jiang, C., Shi, Z., Yu, X. (2023) – 0 citations 🔬
  • Staphylococcus aureus Infection Initiates Hypoxia-Mediated Transforming Growth Factor-b1 Upregulation to Trigger Osteomyelitis – Zhang, W., Lin, Y., Zong, Y., … Zhou, Z., Yu, X. (2022) – 9 citations 🦠
  • Ginsenoside Rg1 enhances the healing of injured tendon in Achilles tendinitis through the activation of IGF1R signaling mediated by oestrogen receptor – Wu, T., Qi, W., Shan, H., … Lu, Y., Wang, F., Yu, X. (2022) – 6 citations 🌱

 

 

 

Serhat Aras | Health Professions | Best Researcher Award

Published on by Global Academic Awards

Assoc. Prof. Dr. Serhat Aras | Health Professions | Best Researcher Award

Assoc. Prof. Dr. Serhat Aras, University of Health Sciences Turkey, Turkey

Assoc. Prof. Dr. Serhat Aras is a nuclear physicist with a Ph.D. from Manisa Celal Bayar University, where he focused on Monte Carlo methods in dose calculations for prostate brachytherapy. He currently serves at the University of Health Sciences, Istanbul, specializing in medical imaging and radiological sciences. Dr. Aras has led research on the radiobiological effects of advanced radiation techniques in cancer treatments, including studies on breast and lung cancer. His teaching includes courses on radiologic imaging, radiation safety, and nuclear medicine. In 2023, he received an International Research Award in India. 🧪📡👨‍🏫

 

Publication Profile

Google Scholar


Academic Background

Dr. Aras completed his PhD in Nuclear Physics at Celal Bayar University, focusing on advanced methodologies for calculating patient doses in prostate brachytherapy using Monte Carlo simulations. His Master’s research also focused on dose distribution in brachytherapy, providing a solid foundation for his contributions to medical physics. His specialized education enhances his capacity to innovate in patient-specific dosimetry, an essential area in clinical radiotherapy.

Professional Experience

Dr. Aras serves in the Medical Imaging Techniques Program at Istanbul Health Sciences University. His roles have included Assistant Professor and Lecturer, where he has imparted his knowledge in courses such as Radiologic Imaging Physics, Radiation Safety, and Nuclear Medicine. His expertise in radiology and medical physics makes him an asset to the field, both in research and education, as he prepares future professionals in these highly technical fields.

Research Projects

Dr. Aras has led numerous research projects in radiobiology and oncology, demonstrating his commitment to advancing medical science. His projects include the study of radiobiological impacts on non-small cell lung cancer xenografts and the protective effects of melatonin and probiotics against radiation-induced tissue damage in experimental rat models. His role as a principal investigator in these studies reflects his leadership and research aptitude, focusing on innovative approaches to radiotherapy and radiation protection.

Awards and Recognition

Dr. Aras received the 2023 International Research Award from ISSN, India, which highlights his global research impact. This accolade, along with his publication record, underscores his contributions to nuclear and medical physics on an international level.

Conclusion

Assoc. Prof. Dr. Serhat Aras’s extensive research in medical imaging, radiotherapy, and radiobiological protection, combined with his teaching and leadership roles, makes him a suitable and commendable candidate for the Best Researcher Award. His contributions to nuclear physics applications in medicine reflect both a commitment to scientific advancement and a positive impact on clinical practices.

 

Publication Top Notes  

  • Dosimetric comparison of three-dimensional conformal radiotherapy (3D-CRT) and intensity modulated radiotherapy techniques (IMRT) with radiotherapy dose simulations for left breast cancer 💉 – Cited by: 41, Year: 2019
  • Dosimetric comparison of superflab and specially prepared bolus materials used in radiotherapy practice 📏 – Cited by: 27, Year: 2020
  • The role of melatonin on acute thyroid damage induced by high dose rate X-ray in head and neck radiotherapy 🌙 – Cited by: 12, Year: 2021
  • Radioprotective effect of melatonin against radiotherapy-induced cerebral cortex and cerebellum damage in rat 🐭 – Cited by: 11, Year: 2020
  • Radiobiological comparison of flattening filter (FF) and flattening filter free (FFF) beam in rat laryngeal tissue 🔬 – Cited by: 8, Year: 2020
  • Home care for mastectomy patients 🏥 – Cited by: 0, Year: 2008
  • A survey study of radiation protection awareness among radiology technicians in Mogadishu, Somalia 🌍 – Cited by: 7, Year: 2020
  • Thoracic re-irradiation for locally recurrent lung cancer 🫁 – Cited by: 5, Year: 2016
  • The dosimetric comparison and evaluation of helical tomotherapy, volumetric-modulated arc radiotherapy (VMAT), step-and-shoot and sliding window radiotherapy techniques in breast cancer 💻 – Cited by: 4, Year: 2022
  • Effect of Flattening Filter and Flattening Filter Free beams on radiotherapy-induced peripheral blood cell damage ⚗️ – Cited by: 4, Year: 2021

 

 

 

 

 

Fei Yu | Medicine and Dentistry | Best Researcher Award

Published on by Global Academic Awards

Fei Yu | Medicine and Dentistry | Best Researcher Award

Prof Fei Yu, Shanghai tenth people’s hospital, China

Prof. Fei Yu, a distinguished expert in Nuclear Medicine, holds a rich educational background with degrees from Soochow University and Fudan University. With a graduation date of June 2012 from Soochow University School of Medicine, he has dedicated himself to advancing the field of Nuclear Medicine through significant contributions and research.

Publication profile

Scopus

Education

Prof. Fei Yu graduated in June 2012 from Soochow University, where he completed his medical education. He previously attended Fudan University from September 1996 to July 2001, earning his degree from the School of Public Health and Community Medicine. Furthering his studies, Prof. Yu obtained his degree from Tongji University’s School of Medicine between March 2005 and March 2008. With a strong foundation in public health and medicine, he has made significant contributions to his field. 🌍📚🏥

Honors and Awards

Prof. Fei Yu is a distinguished researcher recognized for his significant contributions to nuclear medicine. He was awarded the Star of Hope Award by the Chinese Society of Nuclear Medicine in September 2018. His project on targeted therapy for non-small cell lung cancer, supported by the Shanghai Talent Development Fund in September 2017, highlights his innovative approach in the field. He also received the Shanghai Science and Technology Award in November 2010 for developing a 99mTc labeled somatostatin receptor imaging kit for lung cancer diagnosis. Additionally, he was honored with the Huaxia Medical Science and Technology Award and the Hospital Technology Innovation Award for his research on medical ethics and intelligent clinical pathways. 🌟🔬🏆

Research Achievements

Dr. Yang and colleagues have made significant strides in cancer therapy and cardiology. Their 2024 study in Theranostics explores how damaged mitochondrial transfer impacts the bystander effect induced by alpha-particle radiation (🎗️). Another study published in Small reveals that alpha-emitter Radium-223 triggers STING-dependent pyroptosis, enhancing antitumor immunity (💉). Additionally, they developed alpha radionuclide-chelated radioimmunotherapy promoters to advance local radiotherapy strategies, published in Biomaterials Research (📚). In cardiology, their nomogram for predicting major adverse cardiac events in patients with ischemia, featured in Frontiers in Cardiovascular Medicine, is a pivotal contribution (❤️).

Research focus

Prof. Fei Yu is a prominent researcher specializing in nuclear medicine and molecular imaging. His work encompasses the development and evaluation of advanced therapeutic approaches, particularly in the context of neuroendocrine tumors and thyroid cancer. Prof. Yu’s research focuses on innovative treatments like peptide receptor radionuclide therapy and the mechanisms of antitumor immunity, including the role of STING-dependent pyroptosis induced by alpha-emitter Radium-223. His contributions significantly enhance understanding of cancer therapies and their implications for patient prognosis. 🔬💉📈

Memberships and Leadership

Prof. Yu is an active member of several professional societies, holding key positions such as Vice Chairman of the Continuing Education Committee of Nuclear Medicine under the Chinese Nuclear Society. His involvement in these organizations reflects his dedication to the growth and education within the field, emphasizing the importance of collaboration and knowledge sharing.

Funding and Research Projects

Prof. Yu leads multiple funded projects, including the National Natural Science Foundation project on interstitial radiotherapy combined with immunotherapy for non-small cell lung cancer. His work is characterized by a strong focus on innovative therapies that integrate radiological techniques with emerging treatment modalities.

Publication top notes

Triglyceride-glucose index is associated with myocardial ischemia and poor prognosis in patients with ischemia and no obstructive coronary artery disease

The D-SPECT SH reconstruction protocol: improved quantification of small left ventricle volumes

The Effect of Radioiodine Therapy on the Prognosis of Differentiated Thyroid Cancer with Lung Metastases

Extended peptide receptor radionuclide therapy: evaluating nephrotoxicity and therapeutic effectiveness in neuroendocrine tumor patients receiving more than four treatment cycles

Alpha-Emitter Radium-223 Induces STING-Dependent Pyroptosis to Trigger Robust Antitumor Immunity

Conclusion

Prof. Fei Yu exemplifies excellence in nuclear medicine, with a career marked by substantial research contributions, leadership roles, and a commitment to advancing medical science. His innovative approaches to cancer therapy and active involvement in professional societies make him an outstanding candidate for the Best Researcher Award. Prof. Yu’s dedication to improving patient outcomes through research and education sets a high standard for future professionals in the field.